Anti-Fetuin A antibody [EPR9291]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal FETUA antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
FETUA, PRO2743, AHSG, Alpha-2-HS-glycoprotein, Alpha-2-Z-globulin, Ba-alpha-2-glycoprotein, Fetuin-A
- WB
Unknown
Western blot - Anti-Fetuin A antibody [EPR9291] (AB137125)
All lanes:
Western blot - Anti-Fetuin A antibody [EPR9291] (ab137125) at 1/1000 dilution
Lane 1:
HepG2 lysate at 10 µg
Lane 2:
Human fetal liver lysate at 10 µg
Lane 3:
Human plasma lysate at 10 µg
Lane 4:
Human serum lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 39 kDa
false
- WB
CiteAb
Western blot - Anti-Fetuin A antibody [EPR9291] (AB137125)
Fetuin A western blot using anti-Fetuin A antibody [EPR9291] ab137125. Publication image and figure legend from Wang, C. Y., Su, M. T., et al., 2019, Int J Mol Sci, PubMed 31640125.
ab137125 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab137125 please see the product overview.
Fetuin-A is upregulated in the placentas of gestational diabetes mellitus (GDM) patients. (A–C) Fetuin-A is upregulated in the placentas of GDM patients : (A) quantification results of the fetuin-A mRNA level in the placentas of non-GDM and GDM women, (B) whole placenta extracts of non-GDM and GDM women were analyzed by immunoblot with antibodies against fetuin-A and actin, and (C) quantification results in (B). (D,E) Glucose induces the expression of fetuin-A in HTR8 cells : (D) whole cell extracts of fetuin-A-treated HTR8 cells were analyzed by immunoblot with antibodies against fetuin-A and actin and (E) quantitation of the relative intensity of fetuin-A in (E). n.s., no significance; ** p < 0.01 and *** p < 0.001.
false
Related conjugates and formulations (1)
-
Anti-Fetuin A antibody [EPR9291] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
PeerJ 9:e11009 PubMed33763303
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 20: PubMed31640125
2019
Applications
Unspecified application
Species
Unspecified reactive species
Urolithiasis 47:125-135 PubMed29511793
2018
Applications
Unspecified application
Species
Unspecified reactive species
The international journal of biochemistry & cell b 92:63-78 PubMed28919046
2017
Applications
IP
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com